Tofogliflozin, a sodium-glucose cotransporter 2 inhibitor, improves pulmonary vascular remodeling due to left heart disease in mice

Authors:

Abstract
No abstract available
Funding Information
  • Japan Society for the Promotion of Science (19K08495)

This publication has 37 references indexed in Scilit: